As of 2025-09-18, the Intrinsic Value of Athira Pharma Inc (ATHA) is -7.59 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.38 USD, the upside of Athira Pharma Inc is -2,107.37%.
Based on its market price of 0.38 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 2,107.37%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -7.59 - -7.59 | -7.59 | -2,107.37% |
| P/E | (25.77) - (28.35) | (26.90) | -7216.1% |
| DDM - Stable | (13.45) - (38.61) | (26.03) | -6986.5% |
| DDM - Multi | (20.04) - (44.88) | (27.73) | -7434.9% |
| Market Cap (mil) | 14.91 |
| Beta | 1.60 |
| Outstanding shares (mil) | 39.44 |
| Enterprise Value (mil) | -4.98 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.72% |
| Cost of Debt | 5.00% |
| WACC | 6.69% |